Cancer and genetic testing drove diagnostics industry M&A boom in 2020
Cancer and genetic testing drove diagnostics industry M&A boom in 2020 Kelsy Ketchum, 360Dx Print Despite the coronavirus pandemic making waves in economies around the world, the diagnostics market benefitted from increased investor interest and an upswing in mergers and acquisitions in 2020. Overall, the numbers of mergers and acquisitions in the diagnostics industry increased 38% to 54% in 2020 from 39 in 2019. Included in the analysis are deals in the molecular and non-molecular in vitro diagnostic spaces that were announced or completed this past year. In most cases, only acquisitions of...
Source: modernhealthcare.com